Application of magnetic resonance imaging in vivo for the assessement of the progression of systolic and diastolic dysfunction in a mouse model of dilated cardiomyopathy

Kardiologia Polska

Volumn 67, Issue 4, 2009, Pages 386-395

  Drelicharz, Lłukasz ^a   Woźniak, Miroslław ^a   Skórka, Tomasz ^b   Tyrankiewicz, Urszula ^b   Heinze Paluchowska, Sylwia ^b   Jablłońska, Magdalena ^b   Gȩbska, Anna ^a   Chlłopicki, Stefan ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b INSTITUTE OF NUCLEAR PHYSICS   (Poland)

Author keywords

Diastolic dysfunction; Dilated cardiomyopathy; Heart failure; MRI; Transgenic mice

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CLINICAL ASSESSMENT; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DISEASE COURSE; ELECTROCARDIOGRAM; EXPERIMENTAL ANIMAL; EXPERIMENTAL MODEL; FEMALE; HEART CYCLE; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART PAPILLARY MUSCLE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE ENDSYSTOLIC PRESSURE; HEART VENTRICLE PRESSURE; IN VIVO STUDY; LUNG WEIGHT; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAMETER; SURVIVAL; SYSTOLIC DYSFUNCTION; TRANSGENIC MOUSE;

EID: 67650254596     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Paulus WJ, Tschope C, Sanderson JE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007; 28: 2539-2550 (Pubitemid 47614269)
2. Rozentryt P, Nowak J, Sikora J, et al. Cardiomyopathy, asymptomatic dysfunction, acute and chronic heart failure - what does it mean in light of recent guidelines and statements? Kardiol Pol 2008; 66: 200-206
3. Gulec S, Ertas F, Tutar E, et al. Exercise performance in patients with dilated cardiomyopathy: relationship to resting left ventricular function. Int J Cardiol 1998; 65: 247-253 (Pubitemid 28368330)
4. Kowalska A, LŁoboz-Grudzień K, Hirnle T, et al. Left ventricular diastolic function evaluated by Doppler echocardiography in coronary artery disease in relation to to systolic function. Pol Arch Med Wewn 1999; 102: 855-863
5. Skaluba SJ, Litwin SE. Mechanisms of exercise intolerance: insights from tissue Doppler imaging. Circulation 2004; 109: 972-977 (Pubitemid 38282849)
6. Hadano Y, Murata K, Yamamoto T, et al. Usefulness of mitral annular velocity in predicting exercise tolerance in patients with impaired left ventricular systolic function. Am J Cardiol 2006; 97: 1025-1028
7. Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006; 355: 260-269 (Pubitemid 44088349)
8. Fischer M, Baessler A, Hense HW, et al. Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J 2003; 24: 320-328 (Pubitemid 36215965)
9. Skóra E, Bilińska ZT. New therapeutic goals - new drugs in heart failure treatment. Kardiol Pol 2007; 65: 1368-1375
10. Fujii M, Wada A, Tsutamoto T, et al. Bradykinin improves left ventricular diastolic function under long-term angiotensin-converting enzyme inhibition in heart failure. Hypertension 2002; 39: 952-957 (Pubitemid 34547792)
11. Palazzuoli A, Quatrini I, Vecchiato L, et al. Left ventricular diastolic function improvement by carvedilol therapy in advanced heart failure. J Cardiovasc Pharmacol 2005; 45: 563-568 (Pubitemid 40734578)
12. Matter C M, Mandinov L, Kaufmann PA, et al. Effect of NO donors on LV diastolic function in patients with severe pressure-overload hypertrophy. Circulation 1999; 99: 2396-2401 (Pubitemid 29218234)
13. Chen Y, Ohmori K, Mizukawa M, et al. Differential impact of atorvastatin vs. pravastatin on progressive insulin resistance and left ventricular diastolic dysfunction in a rat model of type II diabetes. Circ J 2007; 71: 144-152 (Pubitemid 46045564)
14. Patel C, Wyne KL, McGuire DK. Thiazolidinediones, peripheral oedema and congestive heart failure: what is the evidence? Diab Vasc Dis Res 2005; 2: 61-66 (Pubitemid 40826997)
15. Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003; 362: 777-781 (Pubitemid 37093918)
16. Cleland JG, Tendera M, Adamus J, et al. Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP investigators. Eur J Heart Fail 1999; 1: 211-217 (Pubitemid 30129389)
17. Mende U, Kagen A, Meister M, et al. Signal transduction in atria and ventricles of mice with transient cardiac expression of activated G protein alpha (q). Circ Res 1999; 85: 1085-1091
18. Mende U, Semsarian C, Martins DC, et al. Dilated cardiomyopathy in two transgenic mouse lines expressing activated G protein alpha (q): lack of correlation between phospholipase C activation and the phenotype. J Mol Cell Cardiol 2001; 33: 1477-1491 (Pubitemid 32681666)
19. Mann DL. Pathophysiology of Heart Failure. In: Libby P, Bonow RO, Mann DL, Zipes DP. Braunwald's heart disease a textbook of cardiovascular medicine. Saunders Elsevier 2008, 541
20. LaPointe MC, Mendez M, Leung A, et al. Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse. Am J Physiol Heart Circ Physiol 2004; 286: H1416-24. (Pubitemid 38381150)
21. Gebska A, Olszanecki R, Korbut R. Endotoxaemia in rats: role of leukocyte sequestration in rapid pulmonary nitric oxide synthase-2 expression. J Physiol Pharmacol 2005; 56: 299-311. (Pubitemid 40911095)
22. Heinze-Paluchowska S, Skórka T, Drellicharz LŁ, et al. MR imaging of mouse heart in vivo using a specialized probehead and gradient system. Pol J Chem 2006; 80: 1133-1139 (Pubitemid 44105515)
23. Kosecka S, Wojnar L, Petryniak R, et al. Application of image analysis for quantification of cardiac function in vivo by MRI in the mouse model of heart faiure. Inżynieria Materialłowa 2008; 4: 459-462
24. Bowling N, Walsh RA, Song G, et al. Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart. Circulation 1999; 99: 384-391 (Pubitemid 29051264)
25. D'Angelo DD, Sakata Y, Lorenz JN, et al. Transgenic Galphaq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci U S A 1997; 94: 8121-8126 (Pubitemid 27343787)
26. Takeishi Y, Chu G, Kirkpatrick DM, et al. In vivo phosphorylation of cardiac troponin I by protein kinase Cbeta2 decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts. J Clin Invest 1998; 102: 72-78 (Pubitemid 28323832)
27. Edes IF, Toth A, Csanyi G, et al. Late-stage alterations in myofibrillar contractile function in a transgenic mouse model of dilated cardiomyopathy (Tgalphaq*44). J Mol Cell Cardiol 2008; 45: 363-372
28. Burlew BS, Weber KT. Cardiac fibrosis as a cause of diastolic dysfunction. Herz 2002; 27: 92-98 (Pubitemid 34309394)
29. van Heerebeek L, Borbely A, Niessen HW, et al. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 2006; 113: 1966-1973 (Pubitemid 43754199)
30. Schmidt U, Hajjar RJ, Helm PA, et al. Contribution of abnormal sarcoplasmic reticulum ATPase activity to systolic and diastolic dysfunction in human heart failure. J Mol Cell Cardiol 1998; 30: 1929-1937 (Pubitemid 28495319)
31. Cory CR, Grange RW, Houston ME. Role of sarcoplasmic reticulum in loss of load-sensitive relaxation in pressure overload cardiac hypertrophy. Am J Physiol 1994; 266: H68-78. (Pubitemid 24051494)
32. Elesber AA, Redfield MM, Rihal CS, et al. Coronary endothelial dysfunction and hyperlipidemia are independently associated with diastolic dysfunction in humans. Am Heart J 2007; 153: 1081-1087 (Pubitemid 46823964)
33. Fosslien E. Review: mitochondrial medicine - cardiomyopathy caused by defective oxidative phosphorylation. Ann Clin Lab Sci 2003; 33: 371-395 (Pubitemid 37288648)
34. Diamant M, Lamb HJ, Groeneveld Y, et al. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol 2003; 42: 328-335 (Pubitemid 36851426)
35. Flarsheim CE, Grupp IL, Matlib MA. Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart. Am J Physiol 1996; 271: H192-202. (Pubitemid 126833657)
36. Drelicharz LŁ, Kozlovski V, Skórka T, et al. NO and PGI (2) in coronary endothelial dysfunction in transgenic mice with dilated cardiomyopathy. Basic Res Cardiol 2008; 103: 417-430
37. Elas M, Bielańska J, Pustelny K, et al. Detection of mitochondrial dysfunction by EPR technique in mouse model of dilated cardiomyopathy. Free Radic Biol Med 2008; 45: 321-328
38. Vogt AM, Kubler W. Heart failure: is there an energy deficit contributing to contractile dysfunction? Basic Res Cardiol 1998; 93: 1-10. (Pubitemid 28105288)